We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Daily Aspirin Linked to New Onset Heart Failure

By HospiMedica International staff writers
Posted on 08 Dec 2021
Print article
Image: An aspirin a day might do more harm than good (Photo courtesy of Getty Images)
Image: An aspirin a day might do more harm than good (Photo courtesy of Getty Images)
A new study claims that starting aspirin for secondary prevention of heart failure (HF) can lead to incident HF, independent of other risk factors.

Researchers at the University of Leuven (Belgium), Imperial College London (Imperial; United Kingdom), and other institutions conducted a meta-analysis of 30,827 patients (33.9% female, mean age 66.8 years) at risk for HF, who were enrolled in six observational studies. The study wished to evaluate the role of aspirin use on HF incidence for both primary and secondary prevention. Cardiovascular risk factors and aspirin use were recorded at baseline, and patients were followed up to the first incident of fatal or non-fatal HF.

The results showed that over 5.3 years of follow-up, 1,330 of the patients experienced HF. Overall, the incidence rate of HF per 1,000 person-years for the entire population (before adjustment) was 14.5 in the group on daily aspirin, versus 5.9 in the non-aspirin group. In the 22,690 patients without a prior history of cardiovascular disease (CVD), the HF risk increase for exposure to daily aspirin was about the same. The study was published on November 22, 2021, in ESC Heart Failure.

“These data are not relevant to primary or secondary prevention of cardiovascular events, but refer only to starting aspirin for secondary prevention in patients at high risk of heart failure, or with symptomatic heart failure,” concluded senior author Professor Emeritus Jan Staessen, MD, PhD, of the University of Leuven. “Given the consistency of these results, our observations suggest that aspirin should be prescribed with caution in patients at risk of heart failure or having heart failure.”

Aspirin's efficacy as an anticlotting agent and its widespread use as a preventive treatment for CVD and strokes have made it into one of the most widely used medications in the world. The updated guidelines (issued in March 2019) by the American College of Cardiology (ACC) and the American Heart Association (AHA) suggest that people over age 70 should avoid aspirin if they do not have overt CVD, but that it may still be considered for certain people 40-70 years of age who are at heightened risk of cardiovascular complications.

Related Links:
University of Leuven
Imperial College London


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Steam Sterilizer
2000 RBE

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.